TY - JOUR
T1 - Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice
AU - Zhang, Xin
AU - Li, Lixi
AU - Zhang, Xiaojie
AU - Xie, Wenjie
AU - Li, Liang
AU - Yang, Dehua
AU - Heng, Xin
AU - Du, Yunlan
AU - Doody, Rachelle S.
AU - Le, Weidong
N1 - Funding Information:
The authors acknowledge the joint participation by Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine and this program. The authors thank Profs. Virginia Lee, Center for Neurodegenerative Disease Research of University of Pennsylvania, and Hui Zheng from the Huffington Center on Ageing of Baylor College of Medicine for their critical review of this manuscript, and Mr. Akash Trivedi, University of Texas, Austin for technique help. This work was funded by a research grant from the Chinese National Sciences Foundation (no. 39070925 and no. 81171201 ), 973 National projects (no. 2010CB945200 and no. 2011CB510003), and the Shanghai Science and Technology Program (no. 10410712900 and no. 11JC1414301 ).
PY - 2013/3
Y1 - 2013/3
N2 - Most cases of Alzheimer's disease (AD) arise through interactions between genetic and environmental factors. It is believed that hypoxia is an important environmental factor influencing the development of AD. Our group has previously demonstrated that hypoxia increased β-amyloid (Aβ) generation in aged AD mice. Here, we further investigate the pathological role of prenatal hypoxia in AD. We exposed the pregnant APPSwe/PS1A246E transgenic mice to high-altitude hypoxia in a hypobaric chamber during days 7-20 of gestation. We found that prenatal hypoxic mice exhibited a remarkable deficit in spatial learning and memory and a significant decrease in synapses. We also documented a significantly higher level of amyloid precursor protein, lower level of the Aβ-degrading enzyme neprilysin, and increased Aβ accumulation in the brain of prenatal hypoxic mice. Finally, we demonstrated striking neuropathologic changes in prenatal hypoxic AD mice, showing increased phosphorylation of tau, decreased hypoxia-induced factor, and enhanced activation of astrocytes and microglia. These data suggest that although the characteristic features of AD appear later in life, hypoxemia in the prenatal stage may contribute to the pathogenesis of the disease, supporting the notion that environmental factors can trigger or aggravate AD.
AB - Most cases of Alzheimer's disease (AD) arise through interactions between genetic and environmental factors. It is believed that hypoxia is an important environmental factor influencing the development of AD. Our group has previously demonstrated that hypoxia increased β-amyloid (Aβ) generation in aged AD mice. Here, we further investigate the pathological role of prenatal hypoxia in AD. We exposed the pregnant APPSwe/PS1A246E transgenic mice to high-altitude hypoxia in a hypobaric chamber during days 7-20 of gestation. We found that prenatal hypoxic mice exhibited a remarkable deficit in spatial learning and memory and a significant decrease in synapses. We also documented a significantly higher level of amyloid precursor protein, lower level of the Aβ-degrading enzyme neprilysin, and increased Aβ accumulation in the brain of prenatal hypoxic mice. Finally, we demonstrated striking neuropathologic changes in prenatal hypoxic AD mice, showing increased phosphorylation of tau, decreased hypoxia-induced factor, and enhanced activation of astrocytes and microglia. These data suggest that although the characteristic features of AD appear later in life, hypoxemia in the prenatal stage may contribute to the pathogenesis of the disease, supporting the notion that environmental factors can trigger or aggravate AD.
KW - Alzheimer's disease; Prenatal hypoxia; Learning and memory; Synapses; β-amyloid; Tau protein; Neprilysin; Hypoxia-inducible factor
UR - http://www.scopus.com/inward/record.url?scp=84870523156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870523156&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2012.06.012
DO - 10.1016/j.neurobiolaging.2012.06.012
M3 - Article
C2 - 22795785
AN - SCOPUS:84870523156
SN - 0197-4580
VL - 34
SP - 663
EP - 678
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 3
ER -